BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14610739)

  • 21. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phe-125 and Phe-226 of pig cytochrome P450 1A2 stabilize the binding of aflatoxin B
    Zhu S; Wu J; Liu S; Jiang T; Deng Y
    Biochem Pharmacol; 2019 Aug; 166():292-299. PubMed ID: 31173723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3.
    Crespi CL; Penman BW; Steimel DT; Gelboin HV; Gonzalez FJ
    Carcinogenesis; 1991 Feb; 12(2):355-9. PubMed ID: 1899812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment.
    Tolosa L; Donato MT; Pérez-Cataldo G; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2012 Dec; 26(8):1272-7. PubMed ID: 22138474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification.
    Kelly EJ; Erickson KE; Sengstag C; Eaton DL
    Toxicol Sci; 2002 Jan; 65(1):35-42. PubMed ID: 11752683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
    Van Vleet TR; Klein PJ; Coulombe RA
    J Toxicol Environ Health A; 2002 Jun; 65(12):853-67. PubMed ID: 12079611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninterference of cytochrome P4501A2 in the cytotoxicity of tacrine using genetically engineered V79 Chinese hamster cells for stable expression of the human or rat isoform and two human hepatocyte cell lines.
    Benoit GG; Naud CF; Simard MA; Astier AL
    Biochem Pharmacol; 1997 Feb; 53(3):423-7. PubMed ID: 9065747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
    Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
    Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N; Kodama S; Inui H; Ohkawa H
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.
    Langouët S; Coles B; Morel F; Becquemont L; Beaune P; Guengerich FP; Ketterer B; Guillouzo A
    Cancer Res; 1995 Dec; 55(23):5574-9. PubMed ID: 7585637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
    Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
    Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.
    Uno S; Endo K; Ishida Y; Tateno C; Makishima M; Yoshizato K; Nebert DW
    Toxicol Appl Pharmacol; 2009 May; 237(1):119-26. PubMed ID: 19285097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
    Yanagawa Y; Sawada M; Deguchi T; Gonzalez FJ; Kamataki T
    Cancer Res; 1994 Jul; 54(13):3422-7. PubMed ID: 8012961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
    Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
    Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aflatoxin B
    Deng J; Zhao L; Zhang NY; Karrow NA; Krumm CS; Qi DS; Sun LH
    Mutat Res Rev Mutat Res; 2018; 778():79-89. PubMed ID: 30454686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advance in cytochrome P450 1A2].
    Xiao P; Zhou HH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):456-60. PubMed ID: 18544853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.